Home › Liver Diseases › Florida › Ocala
Liver Diseases clinical trials in Ocala, FL
3 studies for Liver Diseases are looking for participants at sites in and around Ocala (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RecruitingPhase 2
- Ocala GI Research, Ocala
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Ocala
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Ocala
About Liver Diseases
Get the facts about liver diseases, such as hepatitis, cancer, and cirrhosis. Know your risk and what you can do to prevent liver problems.
More about Liver Diseases on MedlinePlus
Liver Diseases trials in other cities
- Chicago, IL10 studies
- Houston, TX10 studies
- Los Angeles, CA8 studies
- Atlanta, GA8 studies
- Washington, DC8 studies
- New York City, NY7 studies
- Richmond, VA6 studies
- San Antonio, TX6 studies
- Philadelphia, PA6 studies
- Aurora, CO5 studies
- Dallas, TX5 studies
- Durham, NC5 studies
Other studies in Ocala
- Non-Small Cell Lung Cancer10 studies
- Obesity7 studies
- Steatotic Liver Disease7 studies
- Alzheimer's Disease6 studies
- Overweight6 studies
- Heart Failure5 studies
- COPD5 studies
- Metastatic Cancer3 studies
- Mild Cognitive Impairment3 studies
- Chronic Pain3 studies
- Atherosclerosis3 studies
- Cardiovascular Disease3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.